Lanfear Dennis M
Insider CIK 1420822 · CHRS See Remarks, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CHRS Coherus Oncology, Inc. | A Award deriv | 2026-05-29 | 2026-06-02 | 500,000 | — | $0 | 500,000 | SEC↗ |
| CHRS Coherus Oncology, Inc. | D To issuer deriv | 2026-05-29 | 2026-06-02 | 200,000 | — | $0 | 0 | SEC↗ |
| CHRS Coherus Oncology, Inc. | D To issuer deriv | 2026-05-29 | 2026-06-02 | 450,000 | — | $0 | 0 | SEC↗ |
| CHRS Coherus Oncology, Inc. | A Award deriv | 2026-05-29 | 2026-06-02 | 450,000 | — | $0 | 450,000 | SEC↗ |
| CHRS Coherus Oncology, Inc. | A Award deriv | 2026-05-29 | 2026-06-02 | 400,000 | — | $0 | 400,000 | SEC↗ |
| CHRS Coherus Oncology, Inc. | A Award deriv | 2026-05-29 | 2026-06-02 | 200,000 | — | $0 | 200,000 | SEC↗ |
| CHRS Coherus Oncology, Inc. | D To issuer deriv | 2026-05-29 | 2026-06-02 | 225,000 | — | $0 | 0 | SEC↗ |
| CHRS Coherus Oncology, Inc. | D To issuer deriv | 2026-05-29 | 2026-06-02 | 402,500 | — | $0 | 0 | SEC↗ |
| CHRS Coherus Oncology, Inc. | D To issuer deriv | 2026-05-29 | 2026-06-02 | 402,500 | — | $0 | 0 | SEC↗ |
| CHRS Coherus Oncology, Inc. | D To issuer deriv | 2026-05-29 | 2026-06-02 | 125,000 | — | $0 | 0 | SEC↗ |
| CHRS Coherus Oncology, Inc. | D To issuer deriv | 2026-05-29 | 2026-06-02 | 500,000 | — | $0 | 0 | SEC↗ |
| CHRS Coherus Oncology, Inc. | D To issuer deriv | 2026-05-29 | 2026-06-02 | 500,000 | — | $0 | 0 | SEC↗ |
| CHRS Coherus Oncology, Inc. | A Award deriv | 2026-05-29 | 2026-06-02 | 225,000 | — | $0 | 225,000 | SEC↗ |
| CHRS Coherus Oncology, Inc. | A Award deriv | 2026-05-29 | 2026-06-02 | 402,500 | — | $0 | 402,500 | SEC↗ |
| CHRS Coherus Oncology, Inc. | A Award deriv | 2026-05-29 | 2026-06-02 | 402,500 | — | $0 | 402,500 | SEC↗ |
| CHRS Coherus Oncology, Inc. | A Award deriv | 2026-05-29 | 2026-06-02 | 125,000 | — | $0 | 125,000 | SEC↗ |
| CHRS Coherus Oncology, Inc. | D To issuer deriv | 2026-05-29 | 2026-06-02 | 400,000 | — | $0 | 0 | SEC↗ |
| CHRS Coherus Oncology, Inc. | A Award deriv | 2026-05-29 | 2026-06-02 | 500,000 | — | $0 | 500,000 | SEC↗ |
| CHRS Coherus Oncology, Inc. | A Award deriv | 2026-01-23 | 2026-01-26 | 750,000 | — | $0 | 750,000 | SEC↗ |
| CHRS Coherus Oncology, Inc. | A Award | 2026-01-23 | 2026-01-26 | 375,000 | — | $0 | 1,048,235 | SEC↗ |
| CHRS Coherus Oncology, Inc. | F Tax w/h | 2026-01-20 | 2026-01-22 | 11,839 | $1.55 | $18.4K | 673,235 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | A Award deriv | 2025-05-07 | 2025-05-09 | 375,000 | — | $0 | 375,000 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | F Tax w/h | 2025-01-20 | 2025-01-22 | 11,810 | $1.39 | $16.4K | 685,074 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | A Award deriv | 2025-01-10 | 2025-01-14 | 575,000 | — | $0 | 575,000 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | F Tax w/h | 2025-01-04 | 2025-01-07 | 11,810 | $1.66 | $19.6K | 696,884 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | A Award deriv | 2024-07-22 | 2024-07-24 | 196,500 | — | $0 | 196,500 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | F Tax w/h | 2024-01-20 | 2024-01-23 | 11,218 | $2.44 | $27.4K | 708,694 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | A Award deriv | 2024-01-05 | 2024-01-08 | 575,000 | — | $0 | 575,000 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | F Tax w/h | 2024-01-04 | 2024-01-08 | 11,781 | $2.92 | $34.4K | 719,912 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | M Exercise deriv | 2023-11-22 | 2023-11-24 | 299,940 | — | $0 | 0 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | M Exercise | 2023-11-22 | 2023-11-24 | 258,940 | $1.42 | $367.7K | 954,793 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | S Sale | 2023-11-22 | 2023-11-24 | 223,100 | $2.02 | $450.7K | 731,693 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | M Exercise | 2023-11-22 | 2023-11-24 | 41,000 | $1.42 | $58.2K | 695,853 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | A Award deriv | 2023-06-13 | 2023-06-15 | 225,000 | — | $0 | 225,000 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | A Award | 2023-01-20 | 2023-01-24 | 86,250 | — | $0 | 654,853 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | A Award deriv | 2023-01-05 | 2023-01-06 | 402,500 | — | $0 | 402,500 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | F Tax w/h | 2023-01-04 | 2023-01-06 | 10,905 | $9.87 | $107.6K | 568,603 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | G Gift | 2022-12-30 | 2023-01-04 | 4,000 | — | $0 | 432,684 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | A Award deriv | 2022-01-04 | 2022-01-06 | 402,500 | — | $0 | 402,500 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | A Award | 2022-01-04 | 2022-01-06 | 86,250 | — | $0 | 579,508 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | G Gift | 2021-11-17 | 2021-11-23 | 10,000 | — | $0 | 436,684 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | M Exercise deriv | 2021-06-08 | 2021-06-08 | 31,054 | — | $0 | 0 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | M Exercise | 2021-06-08 | 2021-06-08 | 31,054 | $0.42 | $13.0K | 524,312 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | S Sale | 2021-06-08 | 2021-06-08 | 31,054 | $13.56 | $421.1K | 493,258 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | M Exercise deriv | 2021-06-06 | 2021-06-08 | 300,000 | — | $0 | 31,054 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | M Exercise | 2021-06-06 | 2021-06-08 | 300,000 | $0.42 | $126.0K | 493,258 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | A Award deriv | 2021-02-01 | 2021-02-03 | 125,000 | — | $0 | 125,000 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | A Award deriv | 2021-01-23 | 2021-01-26 | 500,000 | — | $0 | 500,000 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | M Exercise deriv | 2020-07-01 | 2020-07-06 | 29,994 | — | $0 | 0 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | M Exercise | 2020-07-01 | 2020-07-06 | 29,994 | $0.01 | $300 | 193,258 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | A Award deriv | 2020-01-10 | 2020-01-14 | 500,000 | — | $0 | 500,000 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | F Tax w/h | 2020-01-10 | 2020-01-14 | 21,516 | $17.73 | $381.5K | 163,264 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | A Award | 2020-01-10 | 2020-01-14 | 59,763 | — | $0 | 184,780 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | S Sale | 2019-11-21 | 2019-11-25 | 12,500 | $18.56 | $232.0K | 446,684 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | S Sale | 2019-11-20 | 2019-11-22 | 825,000 | $18.00 | $14.85M | 459,184 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | S Sale | 2019-05-30 | 2019-05-31 | 32,398 | $19.49 | $631.4K | 1,284,184 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | A Award deriv | 2019-01-11 | 2019-01-15 | 450,000 | — | $0 | 450,000 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | A Award | 2019-01-11 | 2019-01-15 | 50,265 | — | $0 | 142,884 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | F Tax w/h | 2019-01-11 | 2019-01-15 | 17,867 | $12.37 | $221.0K | 125,017 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | S Sale | 2018-05-16 | 2018-05-17 | 20,984 | $16.26 | $341.2K | 1,316,582 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | A Award deriv | 2018-02-01 | 2018-02-05 | 400,000 | — | $0 | 400,000 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | A Award | 2017-12-15 | 2017-12-19 | 20,984 | — | $0 | 92,619 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | A Award deriv | 2017-08-06 | 2017-08-08 | 200,000 | — | $0 | 200,000 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | S Sale | 2016-09-21 | 2016-09-22 | 50 | $31.75 | $1.6K | 1,337,566 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | S Sale | 2016-09-20 | 2016-09-22 | 4,010 | $31.75 | $127.3K | 1,337,616 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | S Sale | 2016-09-16 | 2016-09-20 | 2,900 | $31.79 | $92.2K | 1,341,626 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | A Award deriv | 2016-05-11 | 2016-05-13 | 323,889 | — | $0 | 323,889 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | S Sale | 2015-11-30 | 2015-12-02 | 400 | $31.75 | $12.7K | 1,344,526 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | A Award deriv | 2015-05-21 | 2015-05-26 | 35,000 | — | $0 | 35,000 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | A Award deriv | 2015-04-02 | 2015-04-03 | 250,000 | — | $0 | 250,000 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | A Award deriv | 2015-04-02 | 2015-04-03 | 150,000 | — | $0 | 150,000 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | J Other | 2015-03-18 | 2015-03-18 | 13 | — | $0 | 86,965 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | J Other | 2015-03-18 | 2015-03-18 | 2,206 | — | $0 | 1,344,926 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | J Other | 2015-03-18 | 2015-03-18 | 2,084 | — | $0 | 71,635 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | J Other | 2015-03-10 | 2015-03-12 | 828 | — | $0 | 69,551 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | J Other | 2015-03-10 | 2015-03-12 | 799 | — | $0 | 1,342,720 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | J Other | 2015-03-10 | 2015-03-12 | 4 | — | $0 | 86,952 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | G Gift | 2014-12-23 | 2014-12-24 | 20,000 | — | $0 | 1,341,921 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | C Conversion deriv | 2014-11-12 | 2014-11-12 | 5,286 | — | $0 | 0 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | C Conversion deriv | 2014-11-12 | 2014-11-12 | 21,527 | — | $0 | 0 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | C Conversion deriv | 2014-11-12 | 2014-11-12 | 60,135 | — | $0 | 0 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | C Conversion deriv | 2014-11-12 | 2014-11-12 | 3,193 | — | $0 | 0 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | C Conversion deriv | 2014-11-12 | 2014-11-12 | 17,734 | — | $0 | 0 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | X Exercise deriv | 2014-11-12 | 2014-11-12 | 3,225 | $0.02 | $65 | 17,734 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | X Exercise deriv | 2014-11-12 | 2014-11-12 | 3,225 | — | $0 | 0 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | X Exercise deriv | 2014-11-12 | 2014-11-12 | 19,976 | $1.25 | $25.0K | 60,135 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | X Exercise deriv | 2014-11-12 | 2014-11-12 | 19,976 | — | $0 | 0 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | C Conversion | 2014-11-12 | 2014-11-12 | 3,193 | — | $0 | 1,361,921 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | C Conversion | 2014-11-12 | 2014-11-12 | 60,135 | — | $0 | 60,135 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | C Conversion | 2014-11-12 | 2014-11-12 | 21,527 | — | $0 | 81,662 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | C Conversion | 2014-11-12 | 2014-11-12 | 5,286 | — | $0 | 86,948 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | C Conversion | 2014-11-12 | 2014-11-12 | 17,734 | — | $0 | 68,723 | SEC↗ |